TuHURA Biosciences, Inc.
HURA
$2.16
-$0.43-16.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.57% | -38.60% | -59.44% | -117.08% | -- |
| Total Depreciation and Amortization | -16.29% | -38.85% | -50.81% | -29.93% | -- |
| Total Amortization of Deferred Charges | -61.82% | -62.34% | -84.59% | 89.53% | -- |
| Total Other Non-Cash Items | 89.36% | 120.85% | 349.93% | 294.71% | -- |
| Change in Net Operating Assets | -206.10% | -195.80% | -324.21% | 889.65% | -- |
| Cash from Operations | -74.66% | -87.59% | -62.76% | -40.94% | -- |
| Capital Expenditure | 18.19% | -31.61% | 8.53% | 8.53% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 97.88% | 78.99% | 60.30% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 96.76% | 77.94% | 59.55% | -9,510.76% | -- |
| Total Debt Issued | -87.32% | -89.50% | -100.00% | -56.33% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 282.89% | 211.03% | 123.83% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -300.00% | -- | -- | -- | -- |
| Other Financing Activities | 74.25% | 55.42% | -127.20% | -286.49% | -- |
| Cash from Financing | 12.28% | -33.07% | -72.47% | 0.35% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.55% | -200.50% | -208.70% | -145.98% | -- |